Abstract:Background Oral squamous cell carcinoma (OSCC) is the most common type of oral cancer, which remains a major cause of morbidity and mortality in patients with head and neck cancers. However, the critical immune-related signatures and their prognostic values have rarely been investigated. Materials and Methods Gene differential analysis was used to measure the differences of gene expression between the groups. Correlation analysis was used to assess the association between the gene expression levels and immune-related risk score/DNA methylation levels. The gene set enrichment analysis (GSEA) was used to identify the pathways or cell types enriched by those identified differentially expressed genes (DEGs). Results In this study, we identified four immune-related gene signatures, including CTSG, TNFRSF4, LCORL, and PLAU, that were significantly associated with the overall survival in OSCC patients from the Cancer Genome Atlas (TCGA) OSCC cohort. Moreover, these four immune-related signatures were differentially expressed between the OSCC and nontumor tissues. The two groups (high and low risk) stratified by the immune-related risk scores had significantly different OS and mortality rates. The gene expression patterns and prognostic values of these immune-related signatures were also verified in two independent validation cohorts. Furthermore, the downregulated genes in the high-risk group (which were also upregulated in the low-risk group) were significantly enriched in the cell type-specific signatures of type 2 T helper cell (Th2), plasmacytoid dendritic cell (pDC), and memory B cell. In contrast, the upregulated genes in the high-score group were enriched in growth factor receptor-related signaling pathways, such as the VEGFA-VEGFR2 signaling pathway, PI3K-Akt signaling pathway, focal adhesion-PI3K-Akt-mTOR signaling pathway, and PDGF pathway, suggesting that those pathways were inversely correlated with immune cell infiltration. Conclusion In summary, the immune-related signatures had the potential for predicting the risk of OSCC patients. Moreover, the present study also improved our understanding of the association between the growth factor receptor pathways and immune cell infiltration in OSCC.

Label-free tissue proteomics can classify oral squamous cell carcinoma from healthy tissue in a stage-specific manner

Proteomic Diagnosis Models from Serum for Early Detection of Oral Squamous Cell Carcinoma.

A new and preliminary three-dimensional perspective: proteomes of optimization between OSCC and OLK.

Application of Bioinformatics to Optimization of Serum Proteome in Oral Leukoplakia and Oral Squamous Cell Carcinoma

Laser-capture microdissection and protein extraction for protein fingerprint of OSCC and OLK.

Screening Diagnostic Biomarkers of OSCC Via an LCM-based Proteomic Approach

Potential Biomarkers for Oral Squamous Cell Carcinoma: Proteomics Discovery and Clinical Validation

Quantitative Proteomic Analysis of Microdissected Oral Epithelium for Cancer Biomarker Discovery

Discovery and Preclinical Validation of Proteomic Biomarkers in Saliva for Early Detection of Oral Squamous Cell Carcinomas.

Prediction of Oral Cancer Biomarkers by Salivary Proteomics Data

Novel non‐invasive molecular signatures for oral cavity cancer, by whole transcriptome and small non‐coding RNA sequencing analyses: Predicted association with PI3K/AKT/mTOR pathway

A proteomics study of oral mucosa carcinogenesis basing on laser capture microdissection and liquid chromatography-mass spectrometry

Proteomics-based Identification of Haptoglobin As a Novel Plasma Biomarker in Oral Squamous Cell Carcinoma

Saliva protein biomarkers to detect oral squamous cell carcinoma in a high-risk population in Taiwan

Establishment of a new OSCC cell line derived from OLK and identification of malignant transformation-related proteins by differential proteomics approach

Integrated Non-targeted and Targeted Metabolomics Uncovers Amino Acid Markers of Oral Squamous Cell Carcinoma

Comparative Proteomics Approach to Screening of Potential Diagnostic and Therapeutic Targets for Oral Squamous Cell Carcinoma

Identification of Immune-Related Risk Signatures for the Prognostic Prediction in Oral Squamous Cell Carcinoma

Plasma Lipid Profiling and Diagnostic Biomarkers for Oral Squamous Cell Carcinoma

Variation in Plasma Levels of TRAF2 Protein During Development of Squamous Cell Carcinoma of the Oral Tongue

Protein marker profiling in different T classification in laryngeal squamous cell carcinoma.